Timeline

Voting rights breakdown

Gemeldete wirtschaftlich Berechtigte · 25

Eine einzelne, gemeinsam eingereichte Meldung: Der Stimmrechtsanteil gilt für die gesamte Gruppe, nicht für jede Person.

• Aravis Venture I LP41.06%
• Astellas Venture Capital, LLC41.06%
• Auriga Ventures III41.06%
• Baltisches Haus Limited41.06%
• BioMedInvest II LP41.06%
• A/S Dansk Erhvervsinvestering41.06%
• Entrepreneurs Fund General Partners Limited41.06%
• Evolva Holding SA41.06%
• Mona Lisa Capital SA41.06%
• Novartis Bioventures Ltd41.06%
• Renaisance PME fondation suisse d investissement / Mona Lisa41.06%
• Sunstone Life Science Ventures Fund I K/S41.06%
• Symbion Capital I A/S41.06%
• Wellington Partners Ventures III Life Science Fund L.P41.06%
• Wellington Partners Ventures III Life Science Network Fund L41.06%
• Neil Goldsmith41.06%
• Alexandra SantAna Sørensen41.06%
• Pascal Longchamp41.06%
• Jakob Dynnes Hansen41.06%
• Jutta Heim41.06%
• PM Murali41.06%
• Ventureast Trustee Company P Limited41.06%
• APIDC Venture Capital P Limited41.06%
• Vaekstfonden41.06%
• Abunda SR, LLC41.06%

Notice details

Beneficial owner

Aravis Venture I LP

On December 13, 2010 the members of the group (the Lock-up Group) have agreed to partially extend the lock-up undertaking entered into prior to the merger between Arpida Ltd. (now Evolva Holding SA) with Evolva SA with regard to a part of their shares in Evolva Holding SA (the Shares) and conversion rights (as previously disclosed). On 30 May 2011, the participants in Danske Innovationsinvestering (DI), one of the members of the Lock-up Group, decided to liquidate the DI fund and distribute the Evolva shares to its shareholders: Vaekstfonden and A/S A/S Dansk Erhvervsinvestering. On 8 July 2011, Evolva completed the acquisition of Abunda Nutrition, Inc. ("Abunda"). This was executed through a share swap, leading to the issue of 25 million new Evolva shares to the shareholders of Abunda. The former Abunda shareholders acceded to the Lock-up and Coordinated Sale agreement of 13 December 2010, and amended on 17 May 2011. This has led to the increase of the Lock-up Pool by 11,612,138 Evolva shares as well as a change in the composition of the Lock-up Group - triggering the present disclosure. Info regarding the beneficial owners will be made available on the company website, as in previous disclosures. Additional information can be downloaded from the Evolva website www.evolva.com/press-investors/investors/disclosure-shareholdings